NEW YORK, Nov. 4, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the “Class Period”), of the important November 17, 2025 lead plaintiff deadline. So what: If you purchased Cytokinetics common stock… Continue reading CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit
Tag: Strategy
StarCharge and Jardine Engineering Corporation signed an agreement for strategic cooperation on construction of charging network and microgrids
CHANGZHOU, China, Nov. 4, 2025 /PRNewswire/ — On October 21, StarCharge and the Jardine Engineering Corporation Limited (JEC), a premier engineering expert and a wholly owned subsidiary of the Jardine Matheson Group, signed a Memorandum of Understanding for cooperation in the fields of charging network and microgrids. The agreement was signed by Mr. Ethan Li, CEO of… Continue reading StarCharge and Jardine Engineering Corporation signed an agreement for strategic cooperation on construction of charging network and microgrids
Beta Technologies ends first day on NYSE in the green and $1B raised
Shares of electric aviation startup Beta Technologies took flight Tuesday as the company made its debut on the New York Stock Exchange with an outsized raise of $1 billion and a stock price that closed up. The Vermont-based company priced shares in its IPO at $34, above its predicted range of $27 to $33. Beta… Continue reading Beta Technologies ends first day on NYSE in the green and $1B raised
Zepp Health Corporation Reports Third Quarter 2025 Unaudited Financial Results
MILPITAS, Calif., Nov. 4, 2025 /PRNewswire/ — Zepp Health Corporation (“Zepp” or the “Company”) (NYSE: ZEPP) today announced its unaudited financial results for the third quarter of 2025. Third Quarter 2025 Financial and Operating Highlights: Revenue reached US$75.8 million, representing 78.5% year-over-year growth, meeting the upper end of our guidance range. GAAP and adjusted operating… Continue reading Zepp Health Corporation Reports Third Quarter 2025 Unaudited Financial Results
FDA Issues Complete Response Letter for Biohaven’s VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia
Vlad Coric, M.D., Chairman and Chief Executive Officer of Biohaven said, “We are extremely disappointed on behalf of patients by this action from the Office of Neuroscience at FDA. Beyond substantial evidence of safety and efficacy, patients with rare diseases also deserve an efficient, fair and flexible regulatory process that aligns with the urgency of… Continue reading FDA Issues Complete Response Letter for Biohaven’s VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia
Ascletis Presents Full Analysis of Phase Ib Study of ASC30 Oral Tablet, Phase Ib Study of ASC30 Injection, and Preclinical Study of Combination of ASC31 and ASC47 at ObesityWeek® 2025
-Positive data from Phase Ib study of ASC30 oral tablet demonstrated up to 6.5% placebo-adjusted mean body weight reduction; safe and well tolerated with only mild-to-moderate gastrointestinal (GI) adverse events (AEs) across all multiple ascending dose (MAD) cohorts. -Phase Ib study data of ASC30 subcutaneous (SQ) injection showed that observed half-life reached 46 days for… Continue reading Ascletis Presents Full Analysis of Phase Ib Study of ASC30 Oral Tablet, Phase Ib Study of ASC30 Injection, and Preclinical Study of Combination of ASC31 and ASC47 at ObesityWeek® 2025
Multiple Research Results from Innovent’s General Biomedicine Pipeline Showcased at 2025 ACR Annual Meeting
SAN FRANCISCO and SUZHOU, China, Nov. 4, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, announced that pre-clinical study results of IBI3011 (IL-1RAP monoclonal antibody) and IBI3034 (TACI/BCMA… Continue reading Multiple Research Results from Innovent’s General Biomedicine Pipeline Showcased at 2025 ACR Annual Meeting
Health In Tech Announces New Davos 2026 Panel: “First Ladies: Backing Women Who Build” Featuring Cherie Blair CBE, KC
STUART, Fla., Nov. 4, 2025 /PRNewswire/ — Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced an expansion of its agenda for the Independent InsurTech Summit to be held during World Economic Forum Week 2026 in Davos, Switzerland. Following the previously announced CEO panel, “AI and Institutional Resistance:… Continue reading Health In Tech Announces New Davos 2026 Panel: “First Ladies: Backing Women Who Build” Featuring Cherie Blair CBE, KC
Heartland Forward and The Rockefeller Foundation Host “Big Bets for America” to Elevate Solutions Powering the Future
Convening in Oklahoma City brought together more than 200 stakeholders, spanning leading businesses, organizations, governments and philanthropies, focused on helping communities flourish across the heartland and beyond. OKLAHOMA CITY, Nov. 4, 2025 /PRNewswire/ — Heartland Forward and The Rockefeller Foundation co-hosted Big Bets for America: Oklahoma City, a one-day gathering of policymakers, philanthropists, investors, entrepreneurs and… Continue reading Heartland Forward and The Rockefeller Foundation Host “Big Bets for America” to Elevate Solutions Powering the Future
Angel Yeast starts Operating New 11,000-Ton Yeast Protein Production Line to Meet Global Demand for Sustainable Nutrition
YICHANG, China, Nov. 4, 2025 /PRNewswire/ — Angel Yeast Co., Ltd. (SH600298) has officially started operations at its next-generation yeast protein production line at the Baiyang Biotechnology Park in Yichang, Hubei. The facility has an annual production capacity of 11,000 tons of high-purity yeast protein with a protein content exceeding 80%. This marks a key step… Continue reading Angel Yeast starts Operating New 11,000-Ton Yeast Protein Production Line to Meet Global Demand for Sustainable Nutrition